Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206615) titled 'Spot Ex PMCF 01 Study' on Sept. 26.
Study Type: Observational
Primary Sponsor: Laborie Medical Technologies Inc.
Condition:
Presence of Spot Ex Endoscopic Marker
Intervention:
Other: Endoscopic marker
Recruitment Status: Recruiting
Date of First Enrollment: October 2025
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07206615
Published by HT Digital Content Services with permission from Health Daily Digest....